@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix owl: . @prefix dc: . @prefix xsd: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-Q5NG49ZN-H skos:prefLabel "Anthraquinones"@fr, "Anthraquinones"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-T9LDJ61T-L . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-VTVNKZWP-B skos:prefLabel "Antinéoplasiques"@fr, "Antineoplastic Agents"@en ; a mesh:Descriptor, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-MSF3P3V1-C skos:prefLabel "Inhibiteurs de la topoisomérase-II"@fr, "Topoisomerase II Inhibitors"@en ; a mesh:Descriptor, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-HRXVCQ2Z-Q skos:prefLabel "Analgesics"@en, "Analgésiques"@fr ; a mesh:Descriptor, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9LDJ61T-L skos:broader jvr:-Q5NG49ZN-H ; mesh:pharmacologicalAction jvr:-HRXVCQ2Z-Q, jvr:-MSF3P3V1-C, jvr:-VTVNKZWP-B ; mesh:allowableQualifier jvr:-G30ZJ446-J, jvr:-W6SQV79N-S, jvr:-NFTHND7Q-8, jvr:-Q3979798-W, jvr:-R3QWLHRG-V, jvr:-T9HQD7ST-J, jvr:-BT300B3G-Q, jvr:-THHNVC7V-3, jvr:-WK5F724J-1, jvr:-HQRFT0C6-B, jvr:-M63HSDM7-1, jvr:-NKM836P1-M, jvr:-SBNWSM1T-R, jvr:-H7K65Q8S-Z, jvr:-XV06LPML-W, jvr:-R0ZCQ8X6-J, jvr:-D0F21513-5, jvr:-CB30NGKB-3, jvr:-G4R176S9-J, jvr:-NB0XHT3S-N, jvr:-NHL3D2X0-S, jvr:-L6C0XPHT-4, jvr:-TJHVZCRZ-0, jvr:-S0CS1X5R-5, jvr:-FWD2BGQ0-9 ; skos:definition "An anthracenedione-derived antineoplastic agent."@en ; skos:hiddenLabel "Chlorhydrate de mitoxantrone"@fr, "NSC287836"@fr, "NSC301739"@fr, "NSC-301739"@fr, "NSC-301739"@en, "NSC-279836"@en, "NSC-279836"@fr, "CL-232325"@en, "CL-232325"@fr, "Novantron"@en, "Mitoxantrone Hydrochloride"@en, "Acétate de mitoxantrone"@fr, "NSC-301739D"@en, "NSC-301739D"@fr, "NSC299195"@fr, "Onkotrone"@en, "Ralenova"@en, "Novantrone"@en, "NSC-287836"@fr, "NSC-287836"@en, "Mitoxantrone Acetate"@en, "CL232325"@fr, "Mitroxone"@en, "NSC279836"@fr, "NSC301739D"@fr, "Pralifan"@en, "NSC-299195"@en, "NSC-299195"@fr ; a mesh:Descriptor, skos:Concept ; skos:altLabel "Mitozantrone"@en, "70476-82-3 (hydrochloride)"@fr, "70476-82-3 (hydrochloride)"@en, "U6USW86RD0"@fr, "U6USW86RD0"@en, "DHAQ"@en, "65271-80-9 (Mitoxantrone)"@en, "70711-41-0 (acetate)"@fr, "70711-41-0 (acetate)"@en, "65271-80-9 (Mitoxantrone)"@fr, "BZ114NVM5P"@fr, "BZ114NVM5P"@en, "9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-"@fr, "9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-"@en ; skos:inScheme jvr: ; owl:sameAs ; dc:established "1987-01-01"^^xsd:date ; dc:created "1986-06-03"^^xsd:date ; dc:modified "2016-07-01"^^xsd:date ; skos:prefLabel "Mitoxantrone"@en, "Mitoxantrone"@fr . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .